Abstract:Ethnopharmacological relevance: Triptolide (TP) is a major active ingredient and toxic component of Tripterygium wilfordii Hook F (TWHF), which exhibits multiple activities and remarkable hepatotoxicity, the latter of which limits its clinical application due to the risk of liver injury. Previous research has revealed the hepatotoxicity of TP resulting in liver hypersensitivity upon lipopolysaccharide (LPS) stimulation. However, existing research has not elucidated the potential immune mechanism such as Th17/Treg imbalance in TP-induced hepatic excessive immune response to exogenous LPS. Aim of the study: To investigate the role of Th17/Treg imbalance in TP-induced hepatic excessive immune response to exogenous LPS. Materials and methods: Mice were administered with TP, LPS, neutralization antibody and small molecule inhibitor respectively. Serum transaminase level was measured to determine the severity of liver injury. Frequencies of liver Th17 and Treg cells were analyzed by flow cytometry. Serum cytokine levels were performed by ELSIA, and mRNA levels of liver cytokine were performed by qPCR. The status of neutrophil infiltration was performed by myeloperoxidase (MPO) IHC measurement. Morphological observation of liver was performed by hematoxylin and eosin (H&E) staining. Results: Mice given a single intragastric dose of TP (500 mu g/kg) developed lethal fulminant hepatitis following intraperitoneal injection of LPS (0.1 mg/kg), characterized by low survival rate, severe liver injury, high levels of inflammation and neutrophil infiltration. Hepatic Th17/Treg imbalance emerged together with liver injury in these mice. Neutralization of IL-17A attenuated the liver injury and ameliorated the neutrophil infiltration. The TP-induced alteration of hepatic Th17/Treg balance was closely related to the outcome of immune-mediated acute liver injury triggered by LPS. Pretreatment with the STAT3 inhibitor AG490 effectively restored Th17/ Treg balance, significantly reducing the production of IL-17A and finally attenuating the degree of liver injury. Conclusion: Hepatic Th17/Treg imbalance not only exacerbates TP- and LPS-induced liver injury, but also serves as an indispensable part in the mechanisms of TP-induced hepatic intolerance to exogenous endotoxin.

Proteasome activity inhibition mediates endoplasmic reticulum stress-apoptosis in triptolide/lipopolysaccharide-induced hepatotoxicity

A New Perspective of Triptolide-Associated Hepatotoxicity: Liver Hypersensitivity Upon LPS Stimulation.

Quantitative Proteomics and Targeted Fatty Acids Analysis Reveal the Damage of Triptolide in Liver and Kidney

The Role of Inflammasome Activation in Triptolide-induced Acute Liver Toxicity.

Th17/Treg Imbalance Mediates Hepatic Intolerance to Exogenous Lipopolysaccharide and Exacerbates Liver Injury in Triptolide Induced Excessive Immune Response.

Possible Role of Hepatic Macrophage Recruitment and Activation in Triptolide-Induced Hepatotoxicity.

Triptolide Induces Liver Injury by Regulating Macrophage Recruitment and Polarization Via the Nrf2 Signaling Pathway.

The Protective Roles of PPARα Activation in Triptolide-induced Liver Injury.

Role of MicroRNA-155 in Triptolide-induced Hepatotoxicity Via the Nrf2-Dependent Pathway

A new perspective of triptolide-associated hepatotoxicity: the relevance of NF- κ B and NF- κ B-mediated cellular FLICE-inhibitory protein.

Gene expression profiling and pathway analysis of hepatotoxicity induced by triptolide in Wistar rats

Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters.

TP induces hepatic intolerance to FasL-mediated hepatocyte apoptosis by inhibiting XIAP

Triptolide-induced Oxidative Stress Involved with Nrf2 Contribute to Cardiomyocyte Apoptosis Through Mitochondrial Dependent Pathways.

Chlorogenic acid, rutin, and quercetin from Lysimachia christinae alleviate triptolide-induced multi-organ injury in vivo by modulating immunity and AKT/mTOR signal pathway to inhibit ferroptosis and apoptosis

The molecular pathogenesis of triptolide-induced hepatotoxicity

Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide

Triptolide attenuate the oxidative stress induced by LPS/D-GalN in mice.

Activation of Sirt1/FXR Signaling Pathway Attenuates Triptolide-Induced Hepatotoxicity in Rats

Catalpol and Panax Notoginseng Saponins Synergistically Alleviate Triptolide-Induced Hepatotoxicity Through Nrf2/ARE Pathway.

CHIR-98014, a GSK 3β Inhibitor, Protects Against Triptolide/Lipopolysaccharide-Induced Hepatotoxicity by Mitochondria-Dependent Apoptosis Inhibition